Novadip Biosciences is a clinical-stage biopharmaceutical company developing stem-cell derived regenerative tissue products for large bone defects, non-union and spine fusion
Novadip Biosciences is a clinical-stage biopharmaceutical company developing stem-cell derived regenerative tissue products for large bone defects, non-union and spine fusion. The company leverages its unique 3D tissue regeneration technology platform to generate multiple product candidates to address hard and soft tissue reconstruction for patients who have limited or no treatment options.